Prefrontal inefficiency is associated with polygenic risk for schizophrenia.

Considering the diverse clinical presentation and likely polygenic etiology of schizophrenia, this investigation examined the effect of polygenic risk on a well-established intermediate phenotype for schizophrenia. We hypothesized that a measure of cumulative genetic risk based on additive effects of many genetic susceptibility loci for schizophrenia would predict prefrontal cortical inefficiency during working memory, a brain-based biomarker for the disorder. The present study combined imaging, genetic and behavioral data obtained by the Mind Clinical Imaging Consortium study of schizophrenia (n = 255). For each participant, we derived a polygenic risk score (PGRS), which was based on over 600 nominally significant single nucleotide polymorphisms, associated with schizophrenia in a separate discovery sample comprising 3322 schizophrenia patients and 3587 control participants. Increased polygenic risk for schizophrenia was associated with neural inefficiency in the left dorsolateral prefrontal cortex after covarying for the effects of acquisition site, diagnosis, and population stratification. We also provide additional supporting evidence for our original findings using scores based on results from the Psychiatric Genomics Consortium study. Gene ontology analysis of the PGRS highlighted genetic loci involved in brain development and several other processes possibly contributing to disease etiology. Our study permits new insights into the additive effect of hundreds of genetic susceptibility loci on a brain-based intermediate phenotype for schizophrenia. The combined impact of many common genetic variants of small effect are likely to better reveal etiologic mechanisms of the disorder than the study of single common genetic variants.

[1]  P. Goldman-Rakic,et al.  Neuronal and glial somal size in the prefrontal cortex: a postmortem morphometric study of schizophrenia and Huntington disease. , 1998, Archives of general psychiatry.

[2]  T. Wassink,et al.  Cognitive and magnetic resonance imaging brain morphometric correlates of brain-derived neurotrophic factor Val66Met gene polymorphism in patients with schizophrenia and healthy volunteers. , 2006, Archives of general psychiatry.

[3]  J L Rapoport,et al.  The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.

[4]  Stephan Ripke,et al.  Investigation of the Genetic Association between Quantitative Measures of Psychosis and Schizophrenia: A Polygenic Risk Score Analysis , 2012, PloS one.

[5]  T. Schneider-Axmann,et al.  Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning , 2012, European Archives of Psychiatry and Clinical Neuroscience.

[6]  D. Reich,et al.  Population Structure and Eigenanalysis , 2006, PLoS genetics.

[7]  Yusuke Nakamura,et al.  Case–control association study of 59 candidate genes reveals the DRD2 SNP rs6277 (C957T) as the only susceptibility factor for schizophrenia in the Bulgarian population , 2009, Journal of Human Genetics.

[8]  A. Meyer-Lindenberg,et al.  Neural substrates of pleiotropic action of genetic variation in COMT: a meta-analysis , 2010, Molecular Psychiatry.

[9]  Kazuo Yamada,et al.  Genome-Wide Association Study of Schizophrenia in Japanese Population , 2011, PloS one.

[10]  Steven Warach,et al.  Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI , 1999, Biological Psychiatry.

[11]  M. Egan,et al.  Complexity of prefrontal cortical dysfunction in schizophrenia: more than up or down. , 2003, The American journal of psychiatry.

[12]  P. Visscher,et al.  Rare chromosomal deletions and duplications increase risk of schizophrenia , 2008, Nature.

[13]  Michael J. Owen,et al.  Genetics of psychosis; insights from views across the genome , 2009, Human Genetics.

[14]  R. Straub,et al.  Effect of COMT Val108/158 Met genotype on frontal lobe function and risk for schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Trygve E Bakken,et al.  Association of genetic variants on 15q12 with cortical thickness and cognition in schizophrenia. , 2011, Archives of general psychiatry.

[16]  A. Meyer-Lindenberg,et al.  Intermediate phenotypes and genetic mechanisms of psychiatric disorders , 2006, Nature Reviews Neuroscience.

[17]  Randy L. Gollub,et al.  The COMT Val108/158Met polymorphism and medial temporal lobe volumetry in patients with schizophrenia and healthy adults , 2009, NeuroImage.

[18]  Charles E. Vejnar,et al.  Human polymorphism at microRNAs and microRNA target sites. , 2013 .

[19]  Theo G. M. van Erp,et al.  The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects , 2007, Schizophrenia Research.

[20]  F. Lazeyras,et al.  Primary cortical folding in the human newborn: an early marker of later functional development. , 2008, Brain : a journal of neurology.

[21]  S. Lawrie,et al.  The influence of polygenic risk for bipolar disorder on neural activation assessed using fMRI , 2012, Translational Psychiatry.

[22]  M. Munafo,et al.  Lack of association of the COMT (Val158/108 Met) gene and schizophrenia: a meta-analysis of case–control studies , 2005, Molecular Psychiatry.

[23]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[24]  S. Sponheim,et al.  Personality in relation to genetic liability for schizophrenia and bipolar disorder: Differential associations with the COMT Val108/158Met polymorphism , 2008, Schizophrenia Research.

[25]  C. Correll,et al.  Serotonin 6 receptor gene and schizophrenia: case‐control study and meta‐analysis , 2012, Human psychopharmacology.

[26]  Daniel R Weinberger,et al.  Intermediate phenotypes in psychiatric disorders. , 2011, Current opinion in genetics & development.

[27]  A. Cachia,et al.  Cortex morphology in first-episode psychosis patients with neurological soft signs. , 2013, Schizophrenia bulletin.

[28]  Gary Donohoe,et al.  Brain vs behavior: an effect size comparison of neuroimaging and cognitive studies of genetic risk for schizophrenia. , 2013, Schizophrenia bulletin.

[29]  J. Kleinman,et al.  Reduced GSK-3β mRNA levels in postmortem dorsolateral prefrontal cortex of schizophrenic patients , 2004, Journal of Neural Transmission.

[30]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[31]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[32]  J. Meador-Woodruff,et al.  Schizophrenia as a disorder of neuroplasticity. , 2004, International review of neurobiology.

[33]  S. Sponheim,et al.  Anhedonia as a phenotype for the Val158Met COMT polymorphism in relatives of patients with schizophrenia. , 2008, Journal of Abnormal Psychology.

[34]  W H Wong,et al.  Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[35]  D. Lewis,et al.  Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. , 2000, Archives of general psychiatry.

[36]  Pat Levitt,et al.  Analysis of complex brain disorders with gene expression microarrays: schizophrenia as a disease of the synapse , 2001, Trends in Neurosciences.

[37]  S. Potkin,et al.  Genome-wide strategies for discovering genetic influences on cognition and cognitive disorders: Methodological considerations , 2009, Cognitive neuropsychiatry.

[38]  R. Murray,et al.  Disease-associated epigenetic changes in monozygotic twins discordant for schizophrenia and bipolar disorder , 2011, Human molecular genetics.

[39]  Pat Levitt,et al.  Molecular Characterization of Schizophrenia Viewed by Microarray Analysis of Gene Expression in Prefrontal Cortex , 2000, Neuron.

[40]  Jason P. Lerch,et al.  Neurexin-1 and Frontal Lobe White Matter: An Overlapping Intermediate Phenotype for Schizophrenia and Autism Spectrum Disorders , 2011, PloS one.

[41]  J. van os,et al.  Systematic reviews of categorical versus continuum models in psychosis: evidence for discontinuous subpopulations underlying a psychometric continuum. Implications for DSM-V, DSM-VI, and DSM-VII. , 2010, Annual review of clinical psychology.

[42]  D J Holt,et al.  Striatal function in relation to negative symptoms in schizophrenia , 2011, Psychological Medicine.

[43]  Jürgen R. Reichenbach,et al.  Inefficient executive cognitive control in schizophrenia is preceded by altered functional activation during information encoding: An fMRI study , 2008, Neuropsychologia.

[44]  J. Callicott,et al.  Intermediate phenotypes in schizophrenia genetics redux: is it a no brainer? , 2008, Molecular Psychiatry.

[45]  Karl J. Friston,et al.  Synaptic Plasticity and Dysconnection in Schizophrenia , 2006, Biological Psychiatry.

[46]  M. Egan,et al.  Abnormal fMRI response of the dorsolateral prefrontal cortex in cognitively intact siblings of patients with schizophrenia. , 2003, The American journal of psychiatry.

[47]  Scott R Sponheim,et al.  Cumulative genetic risk and prefrontal activity in patients with schizophrenia. , 2013, Schizophrenia bulletin.

[48]  J. Shields,et al.  A polygenic theory of schizophrenia. , 1972, Proceedings of the National Academy of Sciences of the United States of America.

[49]  T. Insel.  Rethinking schizophrenia , 2010, Nature.

[50]  S. Eastwood.  The synaptic pathology of schizophrenia: is aberrant neurodevelopment and plasticity to blame? , 2004, International review of neurobiology.

[51]  R. Buckner,et al.  The association between a polygenic Alzheimer score and cortical thickness in clinically normal subjects. , 2012, Cerebral cortex.

[52]  Lorna M. Lopez,et al.  The genetic association between personality and major depression or bipolar disorder. A polygenic score analysis using genome-wide association data , 2011, Translational Psychiatry.

[53]  G. Kirov,et al.  Polygenic dissection of the bipolar phenotype , 2011, British Journal of Psychiatry.

[54]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[55]  Gail Clement,et al.  A genome-wide study of common SNPs and CNVs in cognitive performance in the CANTAB. , 2009, Human molecular genetics.

[56]  R. D'Agostino,et al.  Genotype score in addition to common risk factors for prediction of type 2 diabetes. , 2008, The New England journal of medicine.

[57]  I S Kohane,et al.  Identification of autoimmune gene signatures in autism , 2011, Translational Psychiatry.

[58]  Nick F. Ramsey,et al.  Left dorsolateral prefrontal cortex dysfunction in medication-naive schizophrenia , 2010, Schizophrenia Research.

[59]  Marisa O. Hollinshead,et al.  Identification of common variants associated with human hippocampal and intracranial volumes , 2012, Nature Genetics.

[60]  S. Fatemi,et al.  The neurodevelopmental hypothesis of schizophrenia, revisited. , 2009, Schizophrenia bulletin.

[61]  L. Mei,et al.  Synaptic dysfunction in schizophrenia. , 2012, Advances in experimental medicine and biology.

[62]  J. Pankow,et al.  Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. , 2007, American journal of epidemiology.

[63]  Carlo Caltagirone,et al.  ZNF804A risk allele is associated with relatively intact gray matter volume in patients with schizophrenia , 2011, NeuroImage.

[64]  Anders D. Børglum,et al.  Genome-wide association study identifies five new schizophrenia loci , 2011, Nature Genetics.